NEW YORK – Eyenovia, Inc., a pharmaceutical company specializing in preparations, announced today a reverse stock split of its common shares in a strategic move to comply with Nasdaq's minimum bid ...

The Company’s Class A Ordinary Shares will begin trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current ticker symbol “NIVF” at the commencement of trading on ...

According to InvestingPro data, the company's stock has ... about Aclarion's financial position and market performance. This news report is based on a press release statement and contains forward ...

The primary aim of this financial maneuver is to enable ... act as the transfer agent for the reverse stock split. The company's forward-looking statements indicate plans for future operations ...

The news should be even better on the other end of the income statement ... trading with market caps above $1,000. A stock split also makes financial sense. The transaction itself is a zero ...

BANGKOK - NewGenIvf Group Limited (NASDAQ:NIVF), a provider of fertility services in Asia with annual revenue of $5.68 ...

Crown Electrokinetics Corp. (NASDAQ: CRKN) ("Crown" or the "Company"), a leading provider of innovative technology infrastructure solutions that benefit ...

Forward-Looking Statements This press release contains ... factors generally affecting the business, operations, and financial condition of the Company; the actual effect of any reverse stock split on ...

The Company’s name and stock symbol are ... Forward-looking statements may include but are not limited to, statements relating to the completion of the Offering on the terms described herein and ...

The auditor report and the consolidated financial statements, which include the impact of the Reverse Stock Split, have been attached as exhibits to the filing. The Form 8-K emphasizes that this ...